ABEONA THERAPEUTICS INC. Active Patents
2 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2022-01-13: Application 17626987; Invention DEVICES, SYSTEMS, AND METHODS FOR PACKAGING AND TRANSPORT OF BIOLOGICAL TISSUE; Applicant Abeona Therapeutics Inc.; Status Patented Case.
- 2021-06-03: Application 17299434; Invention RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR FOR GENE DELIVERY; Applicant Abeona Therapeutics Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-13 | 17626987 | DEVICES, SYSTEMS, AND METHODS FOR PACKAGING AND TRANSPORT OF BIOLOGICAL TISSUE | Abeona Therapeutics Inc. | Patented Case | 2024-11-19 | 12144340 | US20220295783A1 | Phillip B. MAPLES Clarisse ROGAT William G. TEAGS | United States United States United States | NEWAY, BLAINE GIRMA |
| 2021-06-03 | 17299434 | RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR FOR GENE DELIVERY | Abeona Therapeutics Inc. | Patented Case | 2025-10-28 | 12454701 | US20220090129A1 | Timothy J. MILLER Linas PADEGIMAS | United States United States | JOHNSON, ALLISON MARIE |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |